HIV-related admissions to a district general hospital in the UK: a single centre study

被引:5
作者
Udayaraj, Udaya P. [1 ]
Tang, Alan [1 ]
Vaux, Emma [1 ]
Barker, Lindsey [1 ]
Naik, Ramesh [1 ]
机构
[1] Royal Berkshire Hosp, Renal Unit, Reading RG1 5AY, Berks, England
关键词
costs; district general hospital; ethnicity; HIV; immigrants; mortality; ACTIVE ANTIRETROVIRAL THERAPY; INFECTION; MORTALITY; CARE; COST;
D O I
10.7861/clinmedicine.9-4-333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study evaluates the patient and disease characteristics, potential cost implications and short-term outcomes of 64 adult patients admitted with HIV-related illnesses. The majority (65.6%) were black Africans and 75% were immigrants to the UK. Of the 64 patients, 61% were unaware of their HIV status at admission; 50% had CD4 count <50 cells/mu l and 48% had viral load >10(5) copies/ml. Thirty-eight patients had AIDS and this accounted for 66% of the total 897 inpatient days (equivalent to 16.5-30.2 patient years of highly active antiretroviral therapy (HAART) depending on the type of HAART regimen used). Fifteen (23.8%) died in hospital, and of these 11 had AIDS and a CD4 count <200 cells/mu l. Immigrants from countries of high prevalence accounted for the majority of the inpatient HIV caseload. They presented late and had high in-hospital mortality. Screening programmes to allow early diagnosis and treatment should be adapted to reach migrant populations.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 15 条
[1]   Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002) [J].
Beck, E. J. ;
Mandalia, S. ;
Youle, M. ;
Brettle, R. ;
Fisher, M. ;
Gompels, M. ;
Kinghorn, G. ;
McCarron, B. ;
Pozniak, A. ;
Tang, A. ;
Walsh, J. ;
Williams, I. ;
Gazzard, B. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (05) :297-304
[2]  
BECK EJ, 2004, USE COST HIV SERVICE
[3]  
*CTR INF HLTH PROT, 2003, SURV PREV HIV INF DI
[4]  
*DEP HLTH, 2004, GUID EL FREE HOSP TR
[5]  
EVANS B, 2003, AIDS HEPATITIS DIGES, V93, P1
[6]  
Hogg RS, 1998, CLIN INVEST MED, V21, P27
[7]  
Keiser P, 2001, J ACQ IMMUN DEF SYND, V27, P14, DOI 10.1097/00126334-200105010-00003
[8]   Thehigh cost of medical care for patients who present late (CD4&lt; 200 cells/μL) with HIV infection [J].
Krentz, HB ;
Auld, MC ;
Gill, MJ .
HIV MEDICINE, 2004, 5 (02) :93-98
[9]   AIDS across Europe, 1994-98: the EuroSIDA study [J].
Mocroft, A ;
Katlama, C ;
Johnson, AM ;
Pradier, C ;
Antunes, F ;
Mulcahy, F ;
Chiesi, A ;
Phillips, AN ;
Kirk, O ;
Lundgren, JD .
LANCET, 2000, 356 (9226) :291-296
[10]  
MOUTON Y, 1997, AIDS, V11, P101